Probiotic associations in the prevention of necrotising enterocolitis and the reduction of late-onset sepsis and neonatal mortality in preterm infants under 1,500 g: A systematic review;Asociaciones de probióticos para la prevención de la enterocolitis necrosante y la reducción de la sepsis tardía y la mortalidad neonatal en recién nacidos pretérmino de menos de 1.500 g: una revisión sistemática

Anales de Pediatria

Volumn 85, Issue 5, 2016, Pages 247-255

  Baucells, Benjamin James ^a   Mercadal Hally, Maria ^b   Álvarez Sánchez, Airam Tenesor ^c   Figueras Aloy, Josep ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Late onset sepsis; Mortality; Necrotising enterocolitis; Premature infant; Probiotics; Very low birth weight infants

Indexed keywords

PROBIOTIC AGENT;

ENTEROCOLITIS, NECROTIZING; HUMAN; MORTALITY; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; VERY LOW BIRTH WEIGHT;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 84947576974     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2015.07.038     Document Type: Article

References (34)

1. 1 Sharma, R., Hudak, M., A clinical perspective of necrotising enterocolitis: Past, present, and future. Clin Perinatol. 40 (2013), 27–51.
2. 2 Guillet, R., Stoll, B.J., Cotten, C.M., Gantz, M., McDonald, S., Poole, W.K., et al. Association of H2-blocker therapy and higher incidence of necrotising enterocolitis in very low birth weight infants. Pediatrics. 117 (2006), e137–e142.
3. 3 Stoll, B.J., Hansen, N.I., Bell, E.F., Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 126 (2010), 443–456.
4. 4 Waffarn, F., Necrotising enterocolitis and spontaneous intestinal perforation. Gomella, T.L., Eyal, F., Zenk, K., (eds.) Management, procedures, on-call problems, diseases and drugs., 5th ed., 2004, Neonatology, New York, 482–487.
5. 5 Alfaleh, K., Anbrees, J., Bassler, D., al-Kharfi, T., Probiotics for prevention of necrotising enterocolitis in preterm infants. Cochrane Database of Systematic Reviews(Issue 3.), 2011 Art No: CD005496.
6. 6 López Moriana, C., Mach, N., Influencia de la gestación, el parto y el tipo de lactancia sobre la microbiota intestinal del neonato. Acta Pediatr Esp. 72 (2014), 37–44.
7. 7 Infante, D., Redecillas, S., Torrent, A., Segarra, O., Maldonado, M., Gartner, L., et al. Improvement of intestinal function in cystic fibrosis patients using probiotics. An Pediatr. 69 (2008), 501–505.
8. 8 Gutiérrez, P., Polanco, I., An evidence based Iberic-Latin American guideline for acute gastroenteritis management in infants and prescholars. An Pediatr., 72, 2010, 220 e1- e20.
9. 9 Goldmann, D.A., Leclair, J., Macone, A., Bacterial colonisation of neonates admitted to an intensive care environment. J Pediatr 93 (1978), 288–293.
10. 10 O'Toole, P.W., Cooney, J.C., Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis, 85, 2008, 1752.
11. 11 Rijkers, G.T., Bengmark, S., Enck, P., Haller, D., Herz, U., Kalliomaki, S., et al. Guidance for substantiating the evidence for beneficial effects of probiotics: Current status and recommendations for future research. J Nutr 140 (2010), 6715–6765.
12. 12 ILSI Europe. ILSI Europe concise monograph on nutrition and immunity in man. 2nd ed. Brussels: ILSI; 2011.
13. 13 Narbona López, E., Uberos Fernández, J., Armadá Maresca, M.I., Couce Pico, M.L., Rodríguez Martínez, G., Saenz de Pipaon, M., Grupo de Nutrición y Metabolismo Neonatal. Sociedad Española de Neonatología: recomendaciones y evidencias para la suplementación dietética con probióticos en recién nacidos de muy bajo peso al nacer. An Pediatr, 81, 2014, 397 e1- 8.
14. 14 Kliegman, R.M., Walsh, M.C., Neonatal necrotising enterocolitis: Pathogenesis, classification, and spectrum of disease. Curr Probl Pediatr 17 (1987), 243–288.
15. 15 Dani, C., Biadaioli, R., Bertini, G., Martelli, E., Rubaltelli, F., Probiotics feeding in prevention of urinary tract infections, bacterial sepsis and necrotising enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82 (2002), 103–108.
16. 16 Lin, H.C., Su, B.H., Chen, A.C., Lin, T.W., Tsai, C.H., Yeh, T.F., et al. Oral probiotics reduce the incidence and severity of necrotising enterocolitis in very low birth weight infants. Pediatrics 115 (2005), 1–4.
17. 17 Lin, H.C., Hsu, C.H., Chen, H.L., Chung, M.Y., Hsu, J.F., Lien, R.I., et al. Oral probiotics prevent necrotising enterocolitis in very low birth weight preterm infants: A multicentre, randomised, controlled trial. Pediatrics 112 (2008), 693–700.
18. 18 Manzoni, P., Rinaldi, M., Cattani, S., Pugni, L., Romero, M.G., Messner, H., et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomised controlled trial. JAMA 302 (2009), 1421–1428.
19. 19 Rougé, C., Piloquet, H., Butel, M.J., Berger, B., Rochat, F., Ferraris, L., et al. Oral supplementation with probitoics in very low-birth-weight preterm infants: A randomised, double-blind, placebo-controlled trial. Am J Clin Nutr 89 (2009), 1828–1835.
20. 20 Samanta, M., Sarkar, M., Ghosh, P., Ghosh, J., Sinha, M., Chaterjee, S., Prohylactic probiotics for prevention of necrotising enterocolitis in very low birth weight newborns. J Trop Pediatr 55 (2009), 128–131.
21. 21 Sari, F.N., Dizdar, E.A., Oguz, S., Erdeve, O., Uras, N., Dilmen, U., Oral probiotics: Lactobacillus sporogenes for prevention of necrotising enterocolitis in very low-birth-weight infants: A randomised, controlled trial. Eur J Clin Nutr 65 (2011), 434–439.
22. 22 Braga, T., Pontes da Silva, G., Cabral de Lira, P., Lima, M., Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: A double-blind, randomized, controlled trial. Am J Clin Nutr 93 (2011), 81–86.
23. 23 Jacobs, S., Tobin, J., Opie, G., Donath, S., Tabrizi, S., Pirotta, M., et al. Probiotic effects on late-onset sepsis in very preterm infants: A randomised controlled trial. Pediatrics 132 (2013), 1055–1062.
24. 24 Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Gavaghan, D.J., et al. Asessing the quality of reports of randomised clinical trials: Is blinding necessary?. Control Clin Trials. 17 (1996), 1–12.
25. 25 Cochrane Neonatal Group. Neonatal.Cochrane.org [Internet]. The Cochrane Collaboration. [28 Jan 2010; consultado 22 Dec 2014]. Disponible en: http://neonatal.cochrane.org.
26. 26 Marques, W., Toyama, F., Mota, R., Pereira, F., Esteves, V., Alexander, D., Effectiveness of probiotics in the prohylaxis of necrotising enterocolitis in preterm neonates: A systematic review and meta-analysis. J Pediatr (Rio J) 89 (2013), 18–24.
27. 27 AlFaleh, K., Anabrees, J., Bassler, D., Probiotics reduce the risk of necrotising enterocolitis in preterm infants: A meta-analysis. Neonatology 97 (2010), 93–99.
28. 28 Deshpande, G., Rao, S., Patole, S., Bulsara, M., Updated Meta-analysis of probiotics for preventing necrotising enterocolitis in preterm neonates. Pediatrics 125 (2010), 921–930.
29. 29 Wang, Q., Dong, J., Zhu, Y., Probiotic supplement reduces risk of necrotising enterocolitis and mortality in preterm very-low-birth weight infants: An updated meta-analysis of 20 randomised, controlled trials. J Pediatr Surg 47 (2012), 241–248.
30. 30 Mihatsch, W.A., Braegger, C.P., Decsi, T., Kolacek, S., Lanzinger, H., Mayer, B., et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in pre-term infants. Clin Nutr 31 (2012), 6–15.
31. 31 Gonzalez, J., Gonzalez, M., Probióticos y enterocolitis necrotizante del prematuro; to NEC or not to NEC? Esta es la pregunta. Nutr Hosp 28 (2013), 2115–2123.
32. 32 Deshpande, G., Rao, S., Keil, A., Patole, S., Evidence-based guidelines for use of probiotics in preterm neonates. BMC Medicine, 9, 2011, 92.
33. 33 Kosin, B., Rakshit, S., Microbial and processing criteria for production of probiotics: A review. Food Technol Biotechnol 44 (2006), 371–379.
34. 34 Galdeano, C.M., Perdigón G: Role of viabilitiy of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J Appl Microbiol 97 (2004), 673–681.